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For long-term cutaneous gene therapy, the therapeutic gene must be targeted to stem cells and be stably trans-
mitted to and expressed in descendant cells. Retroviral vectors are highly efﬁcient in gene transfer to human
keratinocyte stem cells in culture; however, they cannot transduce quiescent stem cells in vivo. As lentiviral
vectors (LVV) transduce non-proliferating cells, their ability to target human epidermal stem cells was evaluated.
LVV were highly efﬁcient in gene transfer to clonogenic keratinocytes in vitro. Despite higher transgene DNA
content and comparable levels of transgene mRNA, levels of transgene product directed by lentivectors were 3-
folds lower than that of retrovectors. When transduced keratinocytes were grafted onto mice, transgene expression
persisted for at least 20 wk; however, transgene product was detected primarily in the uppermost layers of ep-
idermis. Inclusion of an element that is known to facilitate nuclear export of intron-less transcripts, resulted in
enhanced transgene expression in keratinocytes. In vivo transduction of xenografted human skin with these vec-
tors resulted in efﬁcient gene transfer to epidermal progenitor cells. These results demonstrate stem cell trans-
duction by LVV and point out the utility of using these vectors for direct gene transfer to and sustained expression
in human epidermis.
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Gene therapy approaches are being considered for a variety
of cutaneous disorders for which the genetic basis has been
identified and available therapies are inadequate (Khavari,
2000; Uitto and Pulkkinen, 2000). For long-term cutaneous
gene therapy, the therapeutic gene must be targeted to
long-lived stem cells, and be stably transmitted to and ex-
pressed in descendant cells. In epidermis, stem cells carry
out a life-long process of regeneration and renewal. Stem
cell progeny either remain as stem cells or give rise to transit
amplifying cells which, after a few rounds of replication,
undergo terminal differentiation and desquamate (Hall and
Watt, 1989). Therefore, only gene delivery vehicles that as-
sure stable integration into the stem cell genome are rel-
evant. Consequently, retroviral vectors (RVV) and lentiviral
vectors (LVV) are most useful for long-term gene therapy.
Although both vectors integrate into the host genome, the
entry of retroviral pre-integration complex into the nucleus is
dependent on the breakdown of the nuclear membrane
during M phase (Roe et al, 1993), and therefore transduction
is limited to proliferating cells. Lentiviral genome, however,
can be transported through nuclear pores and integrated
into quiescent as well as proliferating cell genome (Naldini
et al, 1996b).
There are two approaches to cutaneous gene transfer,
the ex vivo approach in which keratinocytes are grown from
skin biopsies and genetically engineered in vitro prior to
grafting, and the in vivo approach that involves direct ad-
ministration of genetic material to intact epidermis. Initial
approaches to cutaneous gene therapy have focused on ex
vivo strategies, as there is substantial experience regarding
in vitro growth and expansion of epidermal keratinocytes
and their clinical application for treatment of burn victims
(Green, 1991; Compton et al, 1998). RVV have been suc-
cessfully used for gene transfer and long-lasting transgene
expression in both keratinocyte culture (Mathor et al, 1996)
and transplantation onto immunodeficient mice (Kolodka et
al, 1998). Ex vivo models of gene therapy for several mon-
ogenic skin disorders including epidermolysis bullosa sub-
types and recessive ichthyoses have been developed
(Freiberg et al, 1997; Dellambra et al, 2000; Robbins et al,
2001; Ortiz-Urda et al, 2002).
Ex vivo approaches to cutaneous gene therapy, however,
are complicated by significant scarring that typically ac-
companies skin autografts. Moreover, the lack of epidermal
appendages in these grafts undermines their capacity to
provide normal skin function. Direct long-term gene transfer
to epidermal stem cells would circumvent these problems.
RVV have been used for direct gene transfer to mouse ep-
idermal stem cells; however, mitotic activation of stem cells
by dermabrasion was required for successful gene transfer
(Ghazizadeh et al, 1999). Direct injection of RVV into human
skin grafted onto immunodeficient mice has not yielded
similar results, partly due to distinct differences in structure
and cell kinetics between mouse and human epidermis
(Gelfant, 1982; Baek et al, 2001).
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Efficient in vivo gene transfer and expression by LVV
have been demonstrated in several other tissues including
muscle, neural, and liver tissues (Naldini et al, 1996b;
Blomer et al, 1997; Kafri et al, 1997). Intradermal injection of
LVV into human skin resulted in persistent gene expression
in skin; however, dermal fibroblasts were the primary targets
(Baek et al, 2001). A systematic evaluation of lentivirus-me-
diated in vivo gene transfer to epidermis demonstrated low
transduction efficiency with no evidence for stem cell tar-
geting. Furthermore, these vectors had no advantage over
that of RVV in gene transfer into keratinocytes progenitor
cells in vitro (Kuhn et al, 2002), despite the presence of
slower cycling of keratinocyte stem cells in culture (Albers
et al, 1986). The objective of this study was to examine
potential mechanisms for the poor performance of LVV
observed in gene transfer to epidermal stem cells. Here we
demonstrate that LVV are highly efficient in gene transfer
and integration to keratinocyte stem cells in vitro and in vivo;
however, lentivirus-mediated transgenes are not properly
expressed in epidermal keratinocytes.
Results
LVV are highly efﬁcient in gene transfer to clonogenic
keratinocytes in culture Cultures of human keratinocytes
contain stem cells, transit amplifying cells and terminally
differentiating cells (Barrandon and Green, 1987), and it is
likely that stem cells in culture replicate more slowly than
transit amplifying cells (Albers et al, 1986). We have previ-
ously shown that clonogenic keratinocytes capable of more
than 30 cumulative population doublings behave as stem
cells in vivo, that is, persist for prolonged periods and gen-
erate differentiated epidermis when grafted onto immuno-
deficient mice (Kolodka et al, 1998). As LVV transduce both
proliferating and quiescent keratinocytes (Kuhn et al, 2002),
they are likely to be more efficient than RVV in gene transfer
to slowly cycling stem cells. To test this hypothesis, sub-
confluent cultures of normal human keratinocytes were
transduced with a Maloney murine leukemia virus-based
retroviral vector (MFGLZ) or human immunodeficiency
virus-based lentiviral vector (HIVLZ) encoding lacZ at var-
ious multiplicity of infections (MOI) ranging from 0.5 to 8.
Two days after transduction, cells were reseeded at clonal
density and 2 wk later, stained for b-gal activity using X-gal
staining. As shown in Fig 1A, HIVLZ was more efficient than
MFGLZ at transducing clonogenic keratinocytes at each
MOI tested. These differences, however, were more pro-
nounced at lower MOI, as there was 4-, 2-, and 1.3-fold-
enhanced transduction by HIVLZ at MOI of 1, 4, and 8,
respectively. The higher rates of transduction of clonogenic
cells by LVV suggest that these vectors are more efficient in
transduction of slow cycling stem cells.
Although HIVLZ was more efficient in transduction of
keratinocytes, levels of b-gal enzyme activity in transduced
cells were significantly lower than that of MFGLZ-trans-
duced keratinocytes, as the time required for X-gal staining
of HIVLZ-transduced keratinocytes was longer (data not
shown). To quantify these differences, b-gal activity in
transduced clones was quantified by incubation of cells in
media including 5-chloromethylfluorescein D-galactopyra-
nocide (CMFDG) substrate reagent, and cellular fluorescent
products were analyzed by flow cytometry. As indicated in
Fig 1B, the average mean fluorescent intensity (MFI) in
MFGLZ-transduced clones was approximately three to four
times higher than that of HIVLZ-transduced clones, indi-
cating significantly lower levels of transgene expression di-
rected by LVV.
LVV-mediated transgene expression is regulated post-
transcriptionally MFGLZ and HIVLZ use different promot-
ers to derive transgene expression. Transgene expression in
MFGLZ is directed by viral promoter located in the long
terminal repeat (LTR) while in HIVLZ, lac Z expression is
driven by an internal cytomegalovirus (CMV) promoter. To
explore whether the low level of b-gal activity in HIVLZ-
transduced keratinocytes was due to lower levels of
Figure1
Lentivirus-mediated transduction of clonogenic keratinocytes in
culture. (A) Transduction efficiencies of clonogenic human keratin-
ocytes transduced at multiplicity of infection (MOI) of 0.5, 1, 2, 4, 8 with
HR’CMVLZ-SIN (HIVLZ) or MFGLZ were measured by X-gal staining of
established colonies of keratinocytes. Error bar indicates standard de-
viation for each group (n¼ 3) in three separate experiments. (B) Trans-
duced clones were expanded for more than 30 population doublings
and b-gal activity in transduced clones (n¼ 18) from each group was
quantified by flow cytometry using CMFDG as a substrate and ex-
pressed as mean fluorescent intensity.
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transcription, keratinocytes were transduced with HIVLZ or
MFGLZ at MOI of 10. At this MOI more than 95% of ker-
atinocytes were transduced and expressed b-gal. Polyclon-
al cultures of transduced keratinocytes were expanded and
used for comparative protein, DNA and RNA analyses (Fig
2). Similar to that observed for transduced clonogenic ker-
atinocytes, b-gal activity in MFGLZ-transduced cultures
was four times higher than that in HIVLZ-transduced cul-
tures (Fig 2A). Southern blot analysis, however, demon-
strated higher copy numbers of lacZ transgene in the
HIVLZ-transduced population, indicating enhanced lentivi-
rus transduction and integration (Fig 2B). But analysis of
total RNA with a lacZ-specific riboprobe indicated compa-
rable levels of lacZ transcript in both MFGLZ- and HIVLZ-
transduced cultures. These data indicated that the differ-
ences observed in levels of b-gal activity are not reflective of
steady-state lacZ transcript levels (Fig 2C) and suggested
that post-transcriptional mechanisms are involved in regu-
lating LVV-mediated transgene expression.
Expression pattern of lentiviral-delivered transgene
product in epidermis To evaluate lentivirus-mediated
transgene expression in epidermis, organotypic cultures
were constructed from polyclonal cultures of HIV-LZ or
MFG-LZ transduced keratinocytes and grafted onto nude
mice. Twenty weeks later following at least five epidermal
turnovers (Kolodka et al, 1998), biopsies were obtained and
b-gal expression in cryosections was assessed by X-gal
staining (Fig 3). Histological examination of grafts generated
from MFGLZ-transduced keratinocytes showed distinct
columns of b-gal positive cells (blue staining) extending
from basal to cornified layers of epidermis (Fig 3A). In grafts
generated from HIVLZ-transduced keratinocytes, however,
X-gal stained cells were observed in the uppermost granular
and cornified layers of epidermis (Fig 3C). No staining was
detected in the lower layers of epidermis. Longer periods of
incubation in X-gal solution resulted in faint staining of cell
clusters in the lower layers of HIVLZ-transduced epidermis
(Fig 3D, arrows), contrary to the intense blue staining of
MFGLZ-transduced tissue. These results indicated persist-
ence of transgene in the epidermis regenerated from HIVLZ-
transduced keratinocytes; however, lentivirus-mediated trans-
gene expression was suppressed in the lower layers of
epidermis.
Figure 2
Post-transcriptional control of lentiviral-mediated transgene ex-
pression in keratinocytes. Human keratinocytes were transduced
with MFGLZ or HIVLZ at an MOI of 10 (95%–96% expressing lacZ).
Transduced cells were expanded and used for comparative protein,
DNA and RNA analyses. Non-transduced was used as a control. (A)
b-gal activity in control and transduced keratinocytes was analyzed by
flow cytometry and expressed as MFI. (B) Southern analysis of gen-
omic DNA isolated from control and transduced keratinocytes as in-
dicated in the figure and hybridized with a lacZ-specific probe. (C) Total
RNA isolated from non-transduced (lane 1), MFGLZ- (lane 2) and HI-
VLZ-transduced keratinocytes (lane 3) and steady-state mRNA levels
for lacZ and b-actin were measured by hybridizing 10 mg total cellular
RNA with specific antisense riboprobes (a 635-nt for lacZ and 270-nt
for b-actin). RNase protected fragments were analyzed by elect-
rophoresis on a 5% denaturing polyacrylamide gel.
Figure3
Histochemical staining of grafted tissue for b-gal expression. Or-
ganotypic raft cultures were constructed with MFGLZ-transduced ker-
atinocytes (A and B) or HIVLZ-transduced keratinocytes (C and D) and
were grafted onto athymic mice. Twenty weeks later tissue was excised
and cryosections were examined for b-gal expression by staining with
X-gal for 1 h (A and C) or 3 h (B and D). b-gal expressing cells are
stained blue. Note lacZ expression in the transitional and cornified lay-
ers of epidermis in C. Sections were counterstained with H&E. Bar
represents 50 mm.
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Inclusion of elements known to facilitate RNA export
in the vector enhance lentivirus-mediated transgene ex-
pression Confinement of lentivirus-mediated lacZ expres-
sion to the uppermost layers of epidermis, a point at which
nuclear disintegration is known to occur (Leigh and Watt,
1994) suggests a block to export nuclear LVV transcripts. A
post-transcriptional regulatory element from woodchuck
hepatitis virus (WPRE) has been shown to facilitate nuclear
export of intron-less transcripts (Huang and Yen, 1995) and
has been shown to enhance retrovirus- and lentivirus-di-
rected transgene expression (Zufferey et al, 1999). To test
whether inclusion of WPRE in the vector results in enhance-
ment of transgene expression in keratinocytes, this element
was inserted in a sense orientation downstream of
enhanced green fluorescent protein (GFP) reporter gene in
pHR’cytomegalovirus (CMV)-GFP to generate pHR’CMV-
GFP-WPRE. GFP was used instead of lacZ for technical
simplicity and to demonstrate that transgene expression
pattern in lentivirus-transduced cells is independent of
transgene. Normal keratinocytes were transduced with
either pHR’CMV-GFP or pHR’CMV-GFP-WPRE and GFP ex-
pression was examined by flow cytometry. As indicated in
Fig 4, inclusion of WPRE in pHR’CMVGFP resulted in 3-fold
increase in the levels of GFP in cultured cells. To assess
GFP expression in epidermal tissue, organotypic rafts were
constructed from transduced keratinocytes and analyzed
histologically. Examination of cryosections indicated GFP
expression in the upper layers of epidermis in pHR’CMV-
GFP (Fig 4B); however, in organotypic cultures generated
from pHR’CMV-GFP-WPRE, GFP was expressed in all lay-
ers of epidermis (Fig 4C). These data indicated that inclusion
of WPRE element could overcome the restrictions observed
in LVV-mediated transgene expression in epidermis.
LVV are efﬁcient in direct gene transfer to human pro-
genitor cells in vivo The potential advantage of LVV
in cutaneous gene therapy is their ability to target slowly
cycling epidermal stem cells in vivo. To examine the feasi-
bility of direct gene transfer to human epidermis, human
foreskins were grafted onto nude mice and were injected
intradermally with concentrated pHR’CMV-GFP-WPRE
(1  107 infectious particles in 20 mL volume). Initial GFP
expression in the transduced skin was assessed at 1 wk
post-transduction in live animals using fluorescent stereos-
copy. As shown in Fig 5A and B, a significant number of
GFP positive cells were observed in the surface of skin
grafts transduced with LVV. Histological examination of
transduced human skin at 10 wk post-transduction by
fluorescent microscopy demonstrated GFP expression in all
layers of epidermis (Fig 5C). The presence of GFP-express-
ing columns in epidermis at this time indicated that pro-
genitor cells were transduced and were capable of giving
rise to differentiated cell descendants. These data clearly
indicate that LVV are efficient in direct gene transfer to
human epidermal progenitor cells and provide a tool for
long-term gene transfer and expression in epidermis.
Discussion
As gene transfer vehicles, LVV’s are advantageous com-
pared with RVV because they can infect quiescent cells,
and are more efficient for in vivo gene transfer (Naldini et al,
1996a). Direct injection of LVV into a variety of tissues in-
cluding neural, muscle, and liver tissues as well as into
quiescent human hematopoietic stem cells results in effi-
cient gene transfer and expression (Blomer et al, 1997; Kafri
et al, 1997; Uchida et al, 1998). In this study, we evaluated
the ability of LVV to mediate stable gene transfer to and
expression in human epidermis. Our data showed that LVV
are superior to RVV in gene transfer to epidermal progenitor
cells in vivo and in vitro. The higher transduction efficiency
of LVV was expected, because epidermal stem cells are
quiescent and not readily targeted by RVV (Bickenbach,
1981; Cotsarelis et al, 1990). Moreover, clonogenic cells in
culture also cycle more slowly (Albers et al, 1986) and un-
der-represented in the RVV-transduced cultures (Kolodka
et al, 1998). The differences between efficiency of gene
transfer to clonogenic cells mediated by LVV and RVV were
more pronounced at low MOI, as at high virus concentration,
Figure 4
WPRE enhances lentivirus-mediated
transgene expression. (A) Kertinocytes
were transduced with HR’CMV-GFP or
HR’CMV-GFP-WPRE at an MOI of 0.3 or
3. Three days post-transduction, GFP
expression in HR’CMV-GFP-transduced
cells (black bars) was compared with that
of HR’CMV-GFP-WPRE-transduced cells
(gray bars). The percent GFP positive
cells in each population is stated above
the bars. This is a representative of three
independent experiments. (B and C)
Three-dimensional raft cultures of human
keratinocytes were constructed using ker-
atinocytes transduced with HR’CMV-GFP
(B) or HR’CMV-GFP-WPRE (C) at an MOI
of 3. Rafts were fixed, cryopreserved and
sections were counterstained with DAPI
(blue nuclear staining) and analyzed for
green fluorescent (green). The position of
basement membrane is indicated with a
dotted line. The bar represents 50 mm.
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almost all keratinocytes were transduced by either vector.
The enhanced gene transfer to keratinocyte stem cells by
LVV was not appreciated in studies of Kuhn et al, 2002, as
cultured keratinocytes were transduced with an MOI of 25.
The higher transduction efficiency by LVV was reflected
in a higher copy number of integrated transgene DNA.
Interestingly, despite these higher copy numbers, steady-
state transgene mRNA levels were comparable between
RVV- and LVV-transduced populations. A direct comparison
between transcriptional activities of the two vectors is dif-
ficult since the promoters driving lacZ expression in these
vectors are not identical. Surprisingly, despite comparable
levels of steady-state transgene mRNA in the two popula-
tions, levels of transgene product in LVV-transduced kera-
tinocytes was 3–4-fold lower than that of RVV-transduced
cells. This lower level was not transgene dependent as
similar results obtained when lacZ was replaced with GFP.
Even more surprising was the pattern of transgene expres-
sion observed in epidermis regenerated from LVV-trans-
duced keratinocytes. High levels of transgene expression
were confined to terminally differentiated keratinocytes in
the upper-granular and the cornified layers of epidermis
where nuclear disintegration is known to occur (Leigh and
Watt, 1994). The high levels of transgene expression in up-
per strata suggested a block in export of lentiviral RNA from
nucleus to cytoplasm in keratinocytes, as high levels of
transgene expression in keratinocytes were correlated with
nuclear degredation (Fig 3). We explored this correlation by
incorporating the WPRE into the LVV genome and noted
improved expression, which suggested that a block to nu-
clear export did limit LVV-transcript expression.
Our data demonstrated stable and high efficiency of
gene transfer to human epidermal cells following direct in-
tradermal injection of WPRE-containing LVV. Transgene ex-
pression persisted at least for 12 wk (duration of analysis)
corresponding to three to four epidermal regeneration in
human epidermis (Potten, 1981). Expression of transgene in
epidermis was confined to vertical columns representing
epidermal proliferating units (Potten, 1974). This is the first
report demonstrating an extensive and durable transgene
expression following direct gene transfer to human epider-
mis. The previous attempts in direct LVV-mediated gene
transfer either resulted in no gene expression by 10 d post-
transduction (Kuhn et al, 2002), or low efficiency of epider-
mal gene transfer (Baek et al, 2001). The extensive epider-
mal gene expression in our studies likely reflects the use of
improved LVV as the number of particles injected was sim-
ilar to that used in other studies.
In summary, our data indicated that LVV are highly effi-
cient in gene transfer to epidermal stem cells. Unlike pre-
vious studies with in vivo transduction of mouse skin
(Ghazizadeh et al, 1999), LVV-mediated transduction of hu-
man epidermis involves little trauma or inflammation. This
improvement in direct gene transfer and expression in hu-
man epidermis provides a powerful research tool and helps
to bring the promise of long-term cutaneous gene therapy
one step closer to reality.
Material and Methods
Cell cultures and construction of organotypic cultures Human
foreskin keratinocytes were grown in submerged cultures in the
presence of irradiated 3T3 cells (Rheinwald and Green, 1975) using
keratinocyte medium described by Wu et al (1982). 293T were
grown in Dulbecco’s minimal essential medium (Gibco/BRL, Grand
Island, New York) supplemented with 10% fetal bovine serum.
Construction of the organotypic cultures has been described
previously (Kolodka et al, 1998). Briefly, transduced keratinocytes
were seeded onto the collagen matrix containing human dermal
fibroblasts, submerged in the media and maintained for 4 d before
raising to the air–liquid interface for an additional 8 d. Cultures
were either grafted onto Swiss nu/nu mice (Taconic Farm, New
York) as described previously (Kolodka et al, 1998), or processed
for histology.
Figure 5
In vivo transduction of xenograted hu-
man epidermis with LVV. Human fore-
skin grafts were injected intradermally
with HR’CMV-GFP-WPRE (5  106 trans-
ducing units in 20 mL) and GFP expression
was assessed in live animals using a
fluorescent stereoscope (A and B). The
boxed region in A is shown at higher
magnification in B to show GFP-express-
ing corneocytes. At 12 wk post-trans-
duction transduced skin was excised,
fixed and cryosections were examined
by fluorescent microscopy. Extensive
GFP expression in the epidermis is shown
in C. A column of GFP expressing cells
representing an epidermal proliferative
unit is shown in D. Tissue sections were
counterstained with DAPI (blue nuclear
staining). In C and D, the position of base-
ment membrane is denoted with a dotted
line. Bar represents 1.2 mm for A, 200 mm
for B, and 50 mm for C and D.
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Viral vectors and transduction Vesicular somatitis virus (VSV)-
G-pseudotyped RVV encoding lacZ (MFGLZ) or enhanced green
fluorescent protein (LZRS-GFP) as reporter genes have been de-
scribed previously (Ghazizadeh et al, 1999; Ghazizadeh et al,
2002). The expression of transgene in these vectors is driven by
viral promoter in LTR. Self-inactivating LVV that express lacZ or
GFP driven by an internal CMV promoter including pHR’CMV-LZ,
pHR’CMV-GFP, and pHR’EF1a-GFP-WPRE were kindly provided
by Dr Didier Trono (CMU, Switzerland). The WPRE from the latter
vector was used to construct pHR’CMV-GFP-WPRE. Lentiviruses
were generated by transient cotransfection of three plasmids into
293T cells including the packaging construct pCMVD8.9, an enve-
lope coding plasmid (pCMV-VSV-G), and the transgene construct.
The virus-containing supernatant was collected 36–72 h after
transfection, filtered through 0.45 mm filter (Gelman Science, Ann
Arbor, Michigan), and stored at 701C. For in vivo transduction,
filtered viral supernatant was concentrated 1000-fold by ultracen-
trifugation as described elsewhere (Burns et al, 1993). Viral titers
were 1–3.0  106 transducing unit per mL as determined on 293T
cells, for all viral stocks used for in vitro transduction and 5  108
transducing units per mL for those used for in vivo transduction.
In vivo transduction Direct gene transfer to mouse epidermis has
been described (Ghazizadeh et al, 1999). As a model for direct
gene transfer to human epidermis, neonatal foreskin was grafted
onto a full thickness, circular 12 mm wound that was created on
the dorsum of 6-wk-old NIH male Swiss nu/nu mice. Grafts were
covered with Vaseline gauze and a polyvinyl bandage to prevent
scratching and facilitate tissue engraftment. The dressing was re-
moved after 10–14 d. Six weeks post-grafting, 20 mL (containing
1  107 CFU) of pHR’CMV-GFP-WPRE were injected intradermally
into the grafted skin with the aid of a 30 gauge needle. At 10 wk
post-transduction, transduced skin was excised, fixed for 30 min in
4% paraformaldehyde on ice, washed in phosphate-buffered sa-
line (PBS), soaked for 30 min in 30% sucrose and cryopreserved.
Animal studies were performed in accordance with institutional
guidelines set forth by the State University of New York.
Detection of transgene products For detection of b-gal express-
ing cells, submerged cultures or cryosections obtained from trans-
duced tissue were fixed for 10 min in 0.2% gluteraldehyde and
stained en face with 1 mg per mL X-gal in 0.1 M sodium phosphate
buffer (pH 7.5) containing 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 1 mM
MgCl2, 0.02% NP-40 and 0.01% sodium deoxycholate until the
blue staining developed. DetectaGene green CMFDG lacZ gene
expression kit (Molecular Probe, Eugene, Oregon) and flow
cytometry were used in some experiments to quantify b-gal ac-
tivity in transduced keratinocytes.
For detection of GFP, transduced cells grown in submerged
cultures were trypsinized, fixed in 2% paraformaldehyde and
analyzed for GFP expression by flow cytometry on a Becton Dic-
kinson FACScan (BD Biosciences, San Jose, California). Skin-di-
rected GFP expression in live animals was assessed using a
fluorescent stereoscope model Bio2-M (Zeiss, Thornwood, New
York) equipped with a mercury 100 W lamp power supply and a
proper filter set for GFP detection. For detection of GFP in trans-
duced skin, cryosections were fixed for 10 min in 4% paraformal-
dehyde, rinsed in PBS, counterstained with 40,6-diamidino-2-
phenylindole (DAPI) and examined by fluorescent microscopy.
DNA and RNA analyses For Southern blot analysis, 5 mg of gen-
omic DNA extracted from transduced cells was digested with BglI,
electrophoresed and transferred to nylon membrane. Equal gel
loading was verified by ethidium bromide staining. A 689-bp dig-
oxigenin-labeled DNA probe specific to lacZ was used for hybrid-
ization. The hybridized probe was detected using the DIG/Genius
Labeling Kit (Roche, Indianapolis, Indiana) according to the man-
ufacturer’s recommendations. Steady-state lacZ transcript levels
were quantified by RNase protection assay using a 635-nt anti-
sense riboprobe specific to lacZ as described previously (Ghazi-
zadeh et al, 1997). A 270 nucleotide for b-actin was used as
internal control for gel loading.
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